Biotech Growth Trust plc (The) (BIOG) Ordinary 25p

- Add to watchlist
- Create an alert
- This stock can be held in a




1,700.00p
1,709.86p
1,706.00p
1,670.24
1,670.00p
1,680.31p
680.00p
-1.21%
20.00p (1.21%) Previous:
20.00p
134,598
n/a
GBX
Price
-
Net Asset Value (NAV)

Performance
1 week 1W | 3.28% | 1 year 1Y | 76.16% |
---|---|---|---|
1 month 1M | 5.16% | 2 years 2Y | 135.88% |
3 months 3M | 16.62% | 3 years 3Y | 116.32% |
6 months 6M | 23.25% | 5 years 5Y | 168.06% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | NASDAQ Biotechnology TR GBP |
---|---|
Annual management charge: | 0.65% of Net Assets |
Performance fee: | Yes |
Ongoing charge: | 1.10% |
Dividend yield: | n/a |
Dividend frequency: | Annually |
Total assets: | £690m |
Gross gearing: | 100% |
Market capitalisation:Market cap.: | £675m |
Shares in issue: | 40.78 million |
Legal structure | Closed Ended Investment Company |
Domicile: | United Kingdom |
ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 1,670.24 |
---|---|
Latest actual NAV: | 1,666.83 |
Latest actual NAV date: | 15 January 2021 |
Premium/Discount: | -1.21% |
12m average Premium/Discount: | -3.48% |
NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Security | Weight |
---|---|
Horizon Therapeutics plc Ordinary Shares | 4.85% |
Neurocrine Biosciences Inc | 4.33% |
Biogen Inc | 4.17% |
Vertex Pharmaceuticals Inc | 3.71% |
Burning Rock Biotech Ltd ADR | 3.62% |
Turning Point Therapeutics Inc | 3.43% |
Alexion Pharmaceuticals Inc | 3.24% |
Amgen Inc | 3.08% |
Acceleron Pharma Inc | 2.99% |
Forte Biosciences Inc Equity Wrt 20/Aug/2021 Usd 1 | 2.91% |
Sector | Weight |
---|---|
Healthcare | 94.10% |
Country | Weight |
---|---|
United States | 70.40% |
China | 9.74% |
Canada | 7.76% |
Switzerland | 2.51% |
United Kingdom | 2.28% |
Cayman Islands | 0.80% |
Ireland | 0.68% |
Denmark | 0.40% |
Germany | 0.31% |
Sweden | 0.02% |
Key Dates
Launch date: | 23 June 1997 |
---|---|
Financial year end: | March |
Next AGM: | July 2021 |

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.